Zhejiang Huahai Pharmaceutical Co Ltd Capital Reinvestment Ratio
Zhejiang Huahai Pharmaceutical Co Ltd capital reinvestment ratio. Zhejiang Huahai Pharmaceutical Co Ltd (600521) has a Capital Reinvestment Ratio of 1.47x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥282.81 Million) in capital expenditures (CN¥414.56 Million). See Zhejiang Huahai Pharmaceutical Co Ltd (600521) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Zhejiang Huahai Pharmaceutical Co Ltd (2001–2025)
Capital reinvestment ratio of Zhejiang Huahai Pharmaceutical Co Ltd from 2001 to 2025. This chart tracks Zhejiang Huahai Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 25 annual periods. See financial flexibility index of Zhejiang Huahai Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
Zhejiang Huahai Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2001–2025)
Zhejiang Huahai Pharmaceutical Co Ltd capital reinvestment ratio by year from 2001 to 2025. For the full cash flow conversion analysis, see Zhejiang Huahai Pharmaceutical Co Ltd (600521) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.60x | CN¥1.23 Billion | CN¥1.97 Billion | ▲ +87.4% |
| 2024 | 0.85x | CN¥2.17 Billion | CN¥1.85 Billion | ▲ +18.8% |
| 2023 | 0.72x | CN¥2.22 Billion | CN¥1.59 Billion | ▼ -61.5% |
| 2022 | 1.86x | CN¥1.24 Billion | CN¥2.32 Billion | ▼ -28.2% |
| 2021 | 2.59x | CN¥938.43 Million | CN¥2.43 Billion | ▲ +216.1% |
| 2020 | 0.82x | CN¥1.56 Billion | CN¥1.28 Billion | ▲ +81.2% |
| 2019 | 0.45x | CN¥1.75 Billion | CN¥794.31 Million | ▼ -97.3% |
| 2018 | 16.56x | CN¥67.90 Million | CN¥1.12 Billion | ▲ +1038.6% |
| 2017 | 1.45x | CN¥546.24 Million | CN¥794.54 Million | ▼ -14.0% |
| 2016 | 1.69x | CN¥433.10 Million | CN¥732.88 Million | ▼ -37.0% |
| 2015 | 2.68x | CN¥195.31 Million | CN¥524.28 Million | ▲ +101.8% |
| 2014 | 1.33x | CN¥328.61 Million | CN¥437.06 Million | ▲ +39.9% |
| 2013 | 0.95x | CN¥490.29 Million | CN¥466.24 Million | ▼ -48.2% |
| 2012 | 1.84x | CN¥243.83 Million | CN¥447.81 Million | ▲ +4.8% |
| 2011 | 1.75x | CN¥197.51 Million | CN¥346.06 Million | ▲ +92.6% |
| 2010 | 0.91x | CN¥299.47 Million | CN¥272.44 Million | ▲ +120.8% |
| 2009 | 0.41x | CN¥317.44 Million | CN¥130.81 Million | ▼ -75.0% |
| 2008 | 1.65x | CN¥84.20 Million | CN¥138.89 Million | ▲ +86.8% |
| 2007 | 0.88x | CN¥136.52 Million | CN¥120.54 Million | ▼ -50.5% |
| 2006 | 1.78x | CN¥77.54 Million | CN¥138.27 Million | ▼ -61.9% |
| 2005 | 4.67x | CN¥53.30 Million | CN¥249.14 Million | ▲ +540.6% |
| 2004 | 0.73x | CN¥163.73 Million | CN¥119.47 Million | ▼ -26.6% |
| 2003 | 0.99x | CN¥47.41 Million | CN¥47.13 Million | ▲ +54.1% |
| 2002 | 0.65x | CN¥75.34 Million | CN¥48.60 Million | ▼ -33.1% |
| 2001 | 0.96x | CN¥37.51 Million | CN¥36.14 Million | — |